UTAH MEDICAL PRODUCTS INC
For the period ended Jun 30, 2026. Filed Aug 12, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 12, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2026-03-31; filed 2026-05-12.
0001096906-26-000767
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsCurrent report: 10-Q
Period ended 2026-06-30; filed 2026-08-12.
0001096906-26-001210
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 8 previous paragraphs and 6 current paragraphs.
4 unchanged; 2 reworded; 0 added; 2 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Removed paragraphs (2)
Previous report
**Item 2.**Unregistered Sales of Equity Securities and Use of Proceeds
Reworded paragraphs (2)
Previous wording
The following table details purchases by UTMD of its own securities during 1Q 2026.
Current wording
The following table details purchases by UTMD of its own securities during 2Q 2026.
Previous wording
1)None of the shares were purchased as part of a publicly announced plan and all were purchased on the open market.
Current wording
1)None of the shares were purchased as part of a publicly announced specific plan, and all were purchased on the open market.